Selank and Semax are two short, synthetic peptides that have attracted growing interest in the longevity and performance medicine space. Both originate from Russian neuropharmacology research and have been studied for their effects on stress regulation, mood, focus and cognitive performance. Increasing numbers of clients in Dubai are asking about them, and they are now widely available, in some cases without medical supervision. The case for using them well is the same as for any peptide therapy. Use the right peptide, at the right dose, for the right person, under proper clinical oversight.
At Shookra in Business Bay, Selank and Semax are available as part of our peptide therapy programme, led by Dr. Hassan Hamdan, our Longevity and Functional Medicine Doctor. Treatment is preceded by consultation and assessment, not delivered on demand. This page explains what each peptide is, what the evidence supports, who they suit, the Shookra protocol pathway, and what to expect.
Both Selank and Semax are short synthetic peptides developed in Russia and used in clinical research over several decades. They share a heritage of neuropeptide research and are often discussed together because of overlapping mechanisms and complementary effects.
Selank is a synthetic analogue of tuftsin, a four-amino-acid immunomodulatory peptide naturally produced in the body. The Selank molecule has been modified to extend its half-life and enhance stability. It is best known for anxiolytic (anxiety-reducing) and nootropic (cognition-supporting) effects. In Russia, Selank is used clinically for the management of generalised anxiety. Outside Russia, it sits within research and longevity medicine settings.
Semax is a heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH) with the C-terminus modified to remove the hormonal activity while retaining neuromodulatory effects. Semax has been studied for cognitive enhancement, stroke recovery support and stress resilience. Like Selank, it has a Russian clinical heritage.
Both peptides are typically delivered as nasal sprays. This route bypasses gastric breakdown and offers reasonable bioavailability for short peptides.
The mechanisms are complex and continue to be studied. The clearest signals from the published research are:
These mechanisms are biologically plausible and supported by preclinical and early clinical research, but human evidence outside Russian publications remains limited. A measured clinical position is appropriate.
Clients and clinicians most commonly explore Selank and Semax for the following reasons. These are areas where research and clinical experience suggest the peptides may support outcomes, not guaranteed results.
The two peptides are sometimes used together, and sometimes alternated, depending on the clinical picture and client goals.
Selank or Semax may be appropriate for clients who are:
They are not a treatment for clinical anxiety, depression or any psychiatric disorder. Clients with diagnosed mental health conditions are best supported by appropriate specialist care, alongside any wellness work.
Honest framing matters with these peptides because much of the online conversation overstates the case.
A good consultation explains what these peptides may help with and what they will not.
Most peptide products in Dubai are sold transactionally. Spray, supplement or product is delivered, with limited clinical input. Shookra works differently.
A typical Selank or Semax pathway includes:
This is the diagnostics-first, doctor-led framework that defines our peptide programme. Selank or Semax is one tool within a wider plan, not a standalone intervention.
Selank and Semax are typically delivered as intranasal sprays. Specific dosing is decided in consultation, based on the clinical picture and goals, and is not provided publicly. As a general guide:
Clients are taught the correct administration technique at consultation and given written guidance.
Selank and Semax are not appropriate for everyone. Treatment may be deferred, declined or adapted where any of the following apply:
A complete medication and history review is part of every consultation. Where Selank or Semax is not appropriate, alternative approaches may be discussed, including conventional support, lifestyle interventions or other peptide pathways.
Selank and Semax are generally well-tolerated when delivered under medical supervision at appropriate doses. Possible side effects include:
Serious adverse events are uncommon at typical research-informed doses under clinical supervision. Clients are encouraged to flag any unexpected effect at follow-up so the protocol can be adjusted.
Selank and Semax are most useful as part of a broader plan, not as a single fix. A typical longevity programme may also include:
Cognitive and mood symptoms often have multiple drivers. The peptides are a useful adjunct, not the whole answer.
Both are short synthetic peptides studied for cognitive and mood support, but they differ in mechanism and emphasis. Selank is a tuftsin analogue with a stronger profile in anxiolytic and stress-tolerance support. Semax is an ACTH-derived peptide with a stronger profile in focus, motivation and cognitive endurance. Some clients use one, some use both, depending on goals and clinical picture.
At typical research-informed doses, under medical supervision, both peptides have a generally favourable tolerability profile. Long-term safety data outside Russian clinical literature remains limited, so we use them in defined cycles, with regular review, and we do not recommend open-ended self-administration.
Some clients notice subtle changes in stress tolerance or focus within days of starting a cycle. Others report more gradual benefit across two to four weeks. Outcomes are individual and we encourage realistic expectations rather than chasing dramatic shifts.
Both peptides are sold in Dubai through various channels, including online and specialist outlets. The clinical risk of self-administration without medical oversight is that contraindications go undetected, dosing is suboptimal, response is not reviewed, and safety markers are not monitored. We strongly recommend medical supervision rather than self-prescribed use.
At typical doses, Selank and Semax do not have an established physical dependence profile in the published literature. That said, no peptide is risk-free, and we treat any chronic uninterrupted use as something to review rather than continue indefinitely.
Possibly, but only with clinical input. Interactions and the broader question of whether peptide therapy is appropriate alongside prescribed psychiatric medication need to be reviewed with your prescribing clinician and our medical team. We will not start a peptide pathway without that picture being clear.
Nootropics span a wide range, from caffeine and L-theanine through to prescription stimulants and other peptides. Selank and Semax are usefully different from stimulants because they support without driving sympathetic load. They sit alongside, not in place of, foundational sleep, training and nutrition work.
If you want to explore whether Selank or Semax could be a useful component of a structured cognitive, stress or longevity programme, our team is ready to help. The pathway begins with a clinical consultation, not a script.
Book a consultation with Dr. Hassan Hamdan to discuss whether Selank or Semax peptide therapy is appropriate for your goals.
Shookra is a DHA-licensed regenerative aesthetics and longevity clinic in Business Bay, Dubai. Our peptide protocols are doctor-led, diagnostics-first and reviewed against measurable response.
